LivaNova (LIVN) Cash from Financing Activities (2015 - 2026)

LivaNova's (LIVN) quarterly Cash from Financing Activities came in at -$94.2 million in Q1 2026, down 2031.76% year-on-year from $4.9 million in Q1 2025, and down 49.87% quarter-over-quarter from -$62.9 million in Q4 2025.

LivaNova (LIVN) Cash from Financing Activities (2015 - 2026) Analysis & Trends

LivaNova has disclosed Cash from Financing Activities across 12 years of filings, most recently posting -$94.2 million for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$94.2 million, down 2031.76% year-over-year; the trailing twelve-month figure through Mar 2026 was -$375.5 million (down 1531.33% YoY), and the FY2025 annual result was -$285.7 million, down 1639.86% from the prior year.
  • Cash from Financing Activities came in at -$94.2 million for Q1 2026 at LivaNova, down from -$62.9 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $214.9 million in Q1 2022 to a low of -$209.0 million in Q2 2025.
  • The 5-year median for Cash from Financing Activities is -$4.4 million (2025), against an average of -$3.5 million.
  • Across the five-year window, Cash from Financing Activities surged 2680.18% in 2022 and slumped 2031.76% in 2026, its largest moves.
  • LivaNova's Cash from Financing Activities stood at -$1.7 million in 2022, then slumped by 202.84% to -$5.0 million in 2023, then surged by 31.37% to -$3.4 million in 2024, then sank by 1725.9% to -$62.9 million in 2025, then plunged by 49.87% to -$94.2 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$94.2 million (Q1 2026), -$62.9 million (Q4 2025), and -$9.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 LivaNova 4.29 Bn 3.71 Bn 243.75 Mn -94.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -94.25 Mn
Mar 31, 2026 -94.25 Mn
Dec 31, 2025 -62.88 Mn
Dec 31, 2025 -62.88 Mn
Sep 30, 2025 -9.37 Mn
Sep 30, 2025 -9.37 Mn
Jun 30, 2025 -208.98 Mn
Jun 30, 2025 -208.98 Mn
Mar 31, 2025 -4.42 Mn
Mar 31, 2025 -4.42 Mn
Dec 31, 2024 -3.44 Mn
Dec 31, 2024 -3.44 Mn
Sep 30, 2024 -3.28 Mn
Sep 30, 2024 -3.28 Mn
Jun 30, 2024 -11.87 Mn
Jun 30, 2024 -11.87 Mn
Mar 31, 2024 37.15 Mn
Mar 31, 2024 37.15 Mn
Dec 31, 2023 -5.02 Mn
Dec 31, 2023 -5.02 Mn